Three-times-weekly dosing (Monday, Wednesday, Friday) and even daily microdosing are theoretically possible and would further flatten the drug concentration curve
Staying Informed About Emerging Research As semaglutide continues to gain popularity as a weight loss medication, ongoing research may provide new insights into optimal dosing strategies
Although todays semaglutide market is largely OOP, falling costs could tip the scales for wider public reimbursement where insurers may be more willing to cover AOMs, in addition to simplifying coverage by removing restrictions such as prior authorisation (see section above on public reimbursement)
Greater weight reduction may also require more careful monitoring, especially for gastrointestinal side effects, hydration, nutrition adequacy, gallbladder symptoms, medication interactions, and muscle preservation